Cathepsin B: a potential prognostic marker for inflammatory breast cancer
- Citation:
- Nouh, M. A., M. M. Mohamed, M. El-Shinawi, M. A. Shaalan, D. Cavallo-Medved, H. M. Khaled, and B. F. Sloane, "Cathepsin B: a potential prognostic marker for inflammatory breast cancer", Journal of Translational Medicine, 2011.
Abstract:
Background: Inflammatory breast cancer (IBC) is the most aggressive form of breast cancer. In non-IBC, the cysteine protease cathepsin B (CTSB) is known to be involved in cancer progression and invasion; however, very little is known about its role in IBC.
Notes:
n/a